KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Treasury Shares (2016 - 2026)

Teva Pharmaceutical Industries filings provide 18 years of Treasury Shares readings, the most recent being $4.1 billion for Q1 2026.

  • On a quarterly basis, Treasury Shares changed 0.0% to $4.1 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $4.1 billion, a 0.0% change, with the full-year FY2025 number at $4.1 billion, changed 0.0% from a year prior.
  • Treasury Shares hit $107.0 million in Q1 2026 for Teva Pharmaceutical Industries, roughly flat from $107.0 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $107.0 million in Q4 2025 to a low of $32.3 million in Q4 2022.
  • Median Treasury Shares over the past 5 years was $106.0 million (2022), compared with a mean of $93.4 million.
  • The widest YoY moves for Treasury Shares: up 0.0% in 2022, down 0.0% in 2022.
  • Teva Pharmaceutical Industries' Treasury Shares stood at $4.1 billion in 2022, then changed by 0.0% to $4.1 billion in 2023, then changed by 0.0% to $4.1 billion in 2024, then changed by 0.0% to $4.1 billion in 2025, then changed by 0.0% to $4.1 billion in 2026.
  • The last three reported values for Treasury Shares were $4.1 billion (Q1 2026), $4.1 billion (Q4 2025), and $4.1 billion (Q3 2025) per Business Quant data.